Skip to main content
NCBI home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 1994 Dec;48(6):538–542. doi: 10.1136/jech.48.6.538

Asymptomatic hyperglycaemia and major ischaemic heart disease events in Britain.

I J Perry 1, S G Wannamethee 1, P H Whincup 1, A G Shaper 1
PMCID: PMC1060028  PMID: 7830006

Abstract

OBJECTIVE--To examine the association between non-fasting serum glucose concentrations and major ischaemic heart disease (IHD) events (fatal and non-fatal myocardial infarction). DESIGN--A prospective study. SUBJECTS--A population based sample of 7735 middle aged British men. Known diabetics, men with a glucose concentration > or = 11.1 mmol/l at screening, and hypertensive patients taking regular medication were excluded from the analysis. With exclusions (n = 509) and missing glucose values (n = 49), there were 7177 men available for analysis. MAIN OUTCOME MEASURES--Major IHD events (fatal and non-fatal myocardial infarction) during 9.5 years follow up on all men. RESULTS--There were 505 major IHD events, 222 fatal and 283 non-fatal, in the 7177 men studied. There was a non-linear relation between the glucose concentration and the risk (per 1000 men per year) of all major IHD events and fatal IHD events, with the excess risk in the upper quintile of the glucose distribution (> or = 6.1 mmol/l). The unadjusted relative risks (RR) in the upper glucose concentration quintile compared with the first to the fourth quintiles combined were 1.4 (95% CI 1.1, 1.7) for all events and 1.3 (95% CI 1.0, 1.7) for fatal events. Adjustment for age, smoking, occupational status, body mass index, physical activity, systolic blood pressure, total and high density lipoprotein cholesterol, and triglyceride concentrations had a minimal effect on these relative risk estimates. This non-linear relationship between the serum glucose concentration and the risk of a major IHD event was observed in men with no evidence of IHD at screening (n = 5518) but not in men with IHD (n = 1659). In the former group, the RR (adjusted for major coronary risk factors) for all major IHD events in the upper quintile relative to the lower quintiles combined was 1.5 (95% CI 1.2, 2.0) and for fatal IHD events was 1.8 (95% CI 1.1, 2.6). CONCLUSION--These data suggest that asymptomatic hyperglycaemia is an independent risk factor for major IHD events.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett-Connor E., Wingard D. L., Criqui M. H., Suarez L. Is borderline fasting hyperglycemia a risk factor for cardiovascular death? J Chronic Dis. 1984;37(9-10):773–779. doi: 10.1016/0021-9681(84)90046-8. [DOI] [PubMed] [Google Scholar]
  2. Butler W. J., Ostrander L. D., Jr, Carman W. J., Lamphiear D. E. Mortality from coronary heart disease in the Tecumseh study. Long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol. 1985 Apr;121(4):541–547. doi: 10.1093/oxfordjournals.aje.a114031. [DOI] [PubMed] [Google Scholar]
  3. Cook D. G., Shaper A. G., Thelle D. S., Whitehead T. P. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J. 1986 Nov;62(733):1001–1006. doi: 10.1136/pgmj.62.733.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Donahue R. P., Abbott R. D., Reed D. M., Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes. 1987 Jun;36(6):689–692. doi: 10.2337/diab.36.6.689. [DOI] [PubMed] [Google Scholar]
  5. Eschwege E., Ducimetiere P., Papoz L., Claude J. R., Richard J. L. Blood glucose and coronary heart disease. Lancet. 1980 Aug 30;2(8192):472–473. doi: 10.1016/s0140-6736(80)91901-7. [DOI] [PubMed] [Google Scholar]
  6. Fontbonne A. M., Eschwège E. M. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care. 1991 Jun;14(6):461–469. doi: 10.2337/diacare.14.6.461. [DOI] [PubMed] [Google Scholar]
  7. Fuller J. H., Shipley M. J. Hyperglycaemia as a cardiovascular risk factor. Postgrad Med J. 1989;65 (Suppl 1):S30–S32. [PubMed] [Google Scholar]
  8. Fuller J. H., Shipley M. J., Rose G., Jarrett R. J., Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 1983 Sep 24;287(6396):867–870. doi: 10.1136/bmj.287.6396.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ganda O. P., Day J. L., Soeldner J. S., Connon J. J., Gleason R. E. Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes. 1978 Jul;27(7):715–725. doi: 10.2337/diab.27.7.715. [DOI] [PubMed] [Google Scholar]
  10. Ganda O. P. Pathogenesis of macrovascular disease in the human diabetic. Diabetes. 1980 Nov;29(11):931–942. doi: 10.2337/diab.29.11.931. [DOI] [PubMed] [Google Scholar]
  11. Helmrich S. P., Ragland D. R., Leung R. W., Paffenbarger R. S., Jr Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991 Jul 18;325(3):147–152. doi: 10.1056/NEJM199107183250302. [DOI] [PubMed] [Google Scholar]
  12. Jarrett R. J., McCartney P., Keen H. The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia. 1982 Feb;22(2):79–84. doi: 10.1007/BF00254833. [DOI] [PubMed] [Google Scholar]
  13. Jarrett R. J., Shipley M. J. Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease--putative association via common antecedents; further evidence from the Whitehall Study. Diabetologia. 1988 Oct;31(10):737–740. doi: 10.1007/BF00274775. [DOI] [PubMed] [Google Scholar]
  14. Kannel W. B., McGee D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035–2038. doi: 10.1001/jama.241.19.2035. [DOI] [PubMed] [Google Scholar]
  15. Lapidus L., Bengtsson C., Blohmé G., Lindquist O., Nyström E. Blood glucose, glucose tolerance and manifest diabetes in relation to cardiovascular disease and death in women. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand. 1985;218(5):455–462. doi: 10.1111/j.0954-6820.1985.tb08874.x. [DOI] [PubMed] [Google Scholar]
  16. Manson J. E., Colditz G. A., Stampfer M. J., Willett W. C., Krolewski A. S., Rosner B., Arky R. A., Speizer F. E., Hennekens C. H. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991 Jun;151(6):1141–1147. [PubMed] [Google Scholar]
  17. Pan W. H., Cedres L. B., Liu K., Dyer A., Schoenberger J. A., Shekelle R. B., Stamler R., Smith D., Collette P., Stamler J. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol. 1986 Mar;123(3):504–516. doi: 10.1093/oxfordjournals.aje.a114266. [DOI] [PubMed] [Google Scholar]
  18. Perry I. J., Wannamethee S. G., Walker M. K., Shaper A. G. Sporting activity and hyperglycemia in middle-aged men. Diabetes Care. 1993 Apr;16(4):581–583. doi: 10.2337/diacare.16.4.581. [DOI] [PubMed] [Google Scholar]
  19. Phillips A. N., Shaper A. G., Pocock S. J., Walker M., Macfarlane P. W. The role of risk factors in heart attacks occurring in men with pre-existing ischaemic heart disease. Br Heart J. 1988 Nov;60(5):404–410. doi: 10.1136/hrt.60.5.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pocock S. J., Ashby D., Shaper A. G., Walker M., Broughton P. M. Diurnal variations in serum biochemical and haematological measurements. J Clin Pathol. 1989 Feb;42(2):172–179. doi: 10.1136/jcp.42.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pocock S. J., Shaper A. G., Phillips A. N. Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. BMJ. 1989 Apr 15;298(6679):998–1002. doi: 10.1136/bmj.298.6679.998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pyörälä K., Laakso M., Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 1987 Apr;3(2):463–524. doi: 10.1002/dmr.5610030206. [DOI] [PubMed] [Google Scholar]
  23. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  24. Salonen J. T. Non-insulin dependent diabetes and ischaemic heart disease. BMJ. 1989 Apr 22;298(6680):1050–1051. doi: 10.1136/bmj.298.6680.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shaper A. G., Pocock S. J., Walker M., Cohen N. M., Wale C. J., Thomson A. G. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J (Clin Res Ed) 1981 Jul 18;283(6285):179–186. doi: 10.1136/bmj.283.6285.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Shaper A. G., Pocock S. J., Walker M., Phillips A. N., Whitehead T. P., Macfarlane P. W. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health. 1985 Sep;39(3):197–209. doi: 10.1136/jech.39.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shaper A. G., Wannamethee G., Weatherall R. Physical activity and ischaemic heart disease in middle-aged British men. Br Heart J. 1991 Nov;66(5):384–394. doi: 10.1136/hrt.66.5.384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Thelle D. S., Shaper A. G., Whitehead T. P., Bullock D. G., Ashby D., Patel I. Blood lipids in middle-aged British men. Br Heart J. 1983 Mar;49(3):205–213. doi: 10.1136/hrt.49.3.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yudkin J. S., Alberti K. G., McLarty D. G., Swai A. B. Impaired glucose tolerance. BMJ. 1990 Sep 1;301(6749):397–402. doi: 10.1136/bmj.301.6749.397. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES